France· FR:60345218
NATRIXAM 1,5 mg/10 mg, comprimé à libération modifiée
A medicinal product containing indapamide + bésilate d'amlodipine, registered in France by BB FARMA (ITALIE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- INDAPAMIDE + BÉSILATE D'AMLODIPINE
- Manufacturer
- BB FARMA (ITALIE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip133400949004973plaquette(s) PVC-Aluminium de 30 comprimé(s)EUR 7.75
- cip133400949004980plaquette(s) PVC-Aluminium de 90 comprimé(s)EUR 21.99
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Indapamide + bésilate d'amlodipine in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsFlutensif 1,5 mg / 10 mg, tabletten met gereguleerde afgifteLes Laboratoires Servier
- FinlandFlutensifLes Laboratoires Servier
- PolandTertens-AMLes Laboratoires Servier
- GermanyNatrixamLes Laboratoires Servier (Suresnes)
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Fludexam
- Bulgaria · Натриксам
- Germany · Natrixam
- Estonia · Flutensif, Natrixam
- Croatia · Natrixam
- Hungary · Cardilopin Komb
- Italy · Frecanstal
- Lithuania · Natrixam
- Luxembourg · Natrixam
- Latvia · Tertensam
- Malta · Natrixam
- Netherlands · Flutensif, Natrixam
- Poland · Tertens-Am
- Portugal · Flutensif, Natrixam
- Romania · Fludexam, Natrixam
- Slovenia · Nadexam
- Slovakia · Flutensif, Natrixam
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ab47da6b-f380-4421-ab4e-c1621ae9f9f6 GET /v1/drugs/ab47da6b-f380-4421-ab4e-c1621ae9f9f6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60345218",
"date_amm": "2021-12-15",
"type_amm": "Autorisation d'importation parallèle",
"numero_ue": null,
"substance": "INDAPAMIDE + BÉSILATE D'AMLODIPINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé à libération modifiée",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about indapamide + bésilate d'amlodipine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.